









Flagship-backed Generate Biomedicines set for Nasdaq debut after $400 million IPO

ReutersFeb 27, 2026 12:48 PM

Drug developer Generate Biomedicines GENB.O, backed by venture firm Flagship Pioneering, set to begin trading on Nasdaq later on Friday under ticker symbol "GENB"

GENB raised $400 million in its IPO by selling 25 million shares at $16 apiece, compared with the marketed range of $15 and $17 apiece

Founded in 2018 by Flagship, Generate's drug pipeline is focused on immunology and oncology

Generate's lead product candidate, GB-0895, to treat severe asthma is being tested in a late-stage trial, which is expected to be fully enrolled by the first half of 2028

"Entering the market with a lead asset already in Phase 3 trials significantly de-risks the company, aligning with the current market trend where investors strongly favor biotech IPOs with advanced clinical assets over purely pre-clinical or early stage portfolios", said IPOX Research Associate Lukas Muehlbauer

Goldman Sachs and Morgan Stanley were joint lead book-running managers for offering

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Tradingkey

Recommended Articles

SpaceX IPO Targets Record 30% Retail Tranche as Musk Echoes Google’s Debut

TradingKey - On March 26, Reuters reported that Elon Musk is discussing allocating up to 30% of SpaceX's IPO shares to retail investors, a proportion triple the conventional level. Typically, companies going public allocate only 5% to 10% of IPO shares to retail investors. Musk's move is reportedly

US Semiconductor Sector Hit by Google TurboQuant Shock, Are AI Storage Stocks Still Worth Investing In?

TradingKey - Google’s newly released TurboQuant technology, originally appearing to be a routine low-level algorithmic optimization, unexpectedly triggered a broad decline in the global semiconductor sector. The core reason is simple: it hits the most sensitive nerve of the current AI industry—memor

Musk’s $1.75T SpaceX IPO: A Historic Bet on Space, AI, and Bitcoin

SpaceX eyes a historic $1.75T IPO, merging aerospace, xAI, and an $580M Bitcoin treasury. With a record $75B raise planned for June 2026, the S-1 filing reveals a vertically integrated giant poised to redefine global capital markets and institutional BTC adoption.

Micron Shares Are Falling, Google TurboQuant Precision Strike? Micron’s AI Memory Empire Is Facing a Test

TradingKey - Shares of Micron Technology (MU) fell 3.4% on Wednesday, marking its fifth consecutive trading session of declines. The latest source of pressure may be Google’s (GOOGL) (GOOG) launch of the TurboQuant compression algorithm.

Samsung, SK Hynix Routed as Google ‘TurboQuant’ Rattles Chip Sector: A ‘Head-Fake’?

TradingKey - Earlier this week, Google unveiled TurboQuant, a new extreme compression algorithm. The algorithm is expected to reduce memory usage by approximately sixfold and boost computing speeds by up to 8x on the same GPU configuration, triggering a broad pullback in the semiconductor sector. Sa

Tradingkey

KeyAI

